102460 — Reyon Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩206bn
- KR₩399bn
- KR₩148bn
Annual cashflow statement for Reyon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,844 | 5,537 | 7,434 | 3,583 | 4,151 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -2,394 | -2,271 | -2,504 | 2,412 | -3,921 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,416 | 3,753 | -734 | -2,132 | -8,010 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,599 | 11,685 | 8,729 | 8,645 | -1,436 |
| Capital Expenditures | -52,424 | -116,997 | -63,133 | -28,872 | -16,023 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 22,829 | 2,315 | 10,569 | 20,133 | -568 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -29,594 | -114,682 | -52,564 | -8,739 | -16,591 |
| Financing Cash Flow Items | -45.3 | -9.23 | — | -3.83 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31,392 | 157,576 | -6,767 | 8,153 | 4,128 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6,371 | 54,544 | -50,691 | 8,058 | -13,898 |